Loading stock data…
CRA International,Inc. (CRAI)
$169.77+2.45 (+1.46%)
Market ClosedLast close Jul 24
CRA International, Inc., together with its subsidiaries, provides economic, financial, and management consulting services worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
CRA International, Inc. in the Industrials sector is trading at $169.77 with a market capitalization of $915M. Wall Street consensus targets $252.50 (2 analysts), implying a +48.7% move over the next 12 months. The stock is currently 25% below its 52-week high of $227.29, remaining 0.6% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +48.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $200.97M↑ | $196.96M↑ | $185.89M↓ | $186.88M↑ | $181.85M |
| Gross Profit | $55.95M↓ | $58.04M↑ | $54.42M↓ | $58.34M↓ | $61.50M |
| Operating Income | $18.03M↓ | $20.64M↑ | $17.21M↓ | $19.73M↓ | $25.55M |
| Net Income | $11.13M↓ | $13.19M↑ | $11.47M↓ | $12.12M↓ | $18.00M |
Peer Comparison
Fundamentals
CRA International, Inc., together with its subsidiaries, provides economic, financial, and management consulting services worldwide. It advises clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guide c...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$914.84M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
19.63
Beta
Defensive asset. Lower volatility than the S&P 500.
0.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.96%
ROE
Elite ROE. Management converts capital into profit efficiently.
24.15%
Volume
Today's trading volume
170,524
Recent News
2 Momentum Stocks with Exciting Potential and 1 We Question
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
3 Market-Beating Stocks with Competitive Advantages
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.
Is CRA International’s New Bria-IMT Role Quietly Redefining Its Healthcare Moat and Pricing Power (CRAI)?
In July 2026, BriaCell Therapeutics Corp. announced it had engaged Charles River Associates (CRA International) and Kaleio, Inc. to support commercial strategy, market access evaluation, and brand planning for Bria-IMT, its investigational metastatic breast cancer therapy currently in a pivotal Phase 3 trial. This engagement highlights how CRA International’s specialized healthcare and market access expertise is being tapped early in the oncology commercialization process, underscoring its...
1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Implied Volatility Surging for CRA International Stock Options
Investors need to pay close attention to CRAI stock based on the movements in the options market lately.